What do regulatory professionals need to be tracking as the FDA begins its new fiscal year? Join regulatory policy and intelligence experts for a fast-paced, lively, and informative look at the biggest regulatory issues that the FDA will be facing in 2024. This session will identify key regulatory issues, critical legislative changes, upcoming guidance and pilot programs from key user fee programs, and our predictions about where FDA is headed next.
Learning Objectives:
Attendees of this session will obtain valuable insights into key issues that could affect their regulatory strategies in 2024, as well as free resources that can help them to prepare for those changes and stay current with regulatory developments.